Home » Newsletters » BioWorld Science

BioWorld Science

March 30, 1999

View Archived Issues

Sulfonylureas linked to increase in early mortality after angioplasty for acute MI

Antiallergic peptide compounds available for licensing from Yeda

NCI initiates pilot trial of thalidomide as adjunct in cancer therapy

Procyon receives Canadian patent for PSP94

Reanalysis of data attributes greater efficacy to Multikine

CuraGen and Roche reach drug discovery agreement

Cantab: 1998 year-end highlights

Small Molecule Therapeutics and Hybrigenics enter drug discovery collaboration

Venous leg ulcers unlikely to heal with compression therapy can be predicted at 4 weeks

U. of California reports new purine cyclin-dependent kinase inhibitors

Suntory synthesizes new inhibitors of PDE4 and TNF-alpha production

Aminoethylphenoxyacetic acids for urinary lithiasis in development at Kissei

New differentiation-inducing vitamin D compounds from Japanese lab

Lilly's new agents for lipid disorders act by increasing HDL cholesterol levels

Glaxo Wellcome seeks U.S. regulatory approval for combination asthma treatment

Hemosol product advances; company receives milestone payment from Fresenius

Boston Biomedica receives 510(k) clearance for Lyme IgM Western Blot test kit

Elastase inhibitor from Teijin looks promising in the treatment of respiratory disease

Suntory's neuroprotective compound SUN-N4057 is effective in rat models

Preclinical studies support BM-17.0744 as a potential treatment for metabolic syndrome

HMR-1883: not a classical antiarrhythmic agent

Studies show that ketolide compound ABT-773 is a promising new antimicrobial agent

Bristol-Myers Squibb drops antimigraine drug from the pipeline

In vitro data supporting antifungal efficacy of Nyotran presented at ECCMID

New antileukemia agents synthesized at Hughes Institute

More news from the ACS: DuPont synthesizes anti-HIV compounds derived from efavirenz

ACS highlights: Dainippon selects potent antitumor compound for development

NovoSeven approved in the U.S.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...